Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a monthly podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at http://EndocrinologyNetwork.com.
Please direct any podcast-related inquiries to PCampbell@MJHLifesciences.com.
Editor's note: Episodes predating March 2022 were hosted as The Endocrine Outlook.
Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MD
In this episode, our hosts are joined by Lydia Alexander, MD, president-elect of the Obesity Medicine Association, to discuss the updates in the landscape of obesity management as well as a deep dive into the recent American Gastroenterological Association guidelines for pharmacological management and the OMA's annual meeting.
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the ongoing GLP-1 RA shortage and whether or not celebrities using these agents for weight loss is a real issue in the community as well as provide insight into their top takeaways from the ADA/KDIGO consensus report.
Diabetes Dialogue: EASD 2022 and Recent CGM News
In this special edition episode of Diabetes Dialogue, our hosts break down their top clinical takeaways from the European Association for the Study of Diabetes 2022 annual meeting, new data from the FLASH-UK trial, the global launch of Dexcom G7, and the announcement of US availability for the FreeStyle Libre 3.
Diabetes Dialogue: September 2022
In the September 2022 episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide their own perspective on DIY looping based on the results of a recent study published in the New England Journal of Medicine and also break down a new set of consensus recommendations for the use of automated insulin delivery (AID) systems in clinical practice published in Endocrine Reviews, which Isaacs helped compose as a member of the writing committee.
Diabetes Dialogue: ADCES 2022 Recap
In this episode of Diabetes Dialogue, which was filmed days after the conclusion of ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the conference, their favorite sessions, and how ADCES meetings have evolved to the changing role of diabetes care and education specialists over the years.
Diabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD
In this edition of Diabetes Dialogue, which was filmed on-site at ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with Jennifer Clements, PharmD, following her sessions to discuss her work, her upcoming research interests, and ongoing trends in the field of diabetes management. During her time at the meeting, Clements was the primary presenter for a trio of sessions focus on U-500 insulin in the inpatient setting, treatment and prevention strategies for hypoglycemia, and clinical implications for SGLT2 inhibitors.